365 related articles for article (PubMed ID: 17289614)
21. [From gene to disease; HFE-mutations in primary haemochromatosis].
Swinkels DW; Jacobs EM
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):652-6. PubMed ID: 12712648
[TBL] [Abstract][Full Text] [Related]
22. Role of early case detection by screening relatives of patients with HFE-associated hereditary haemochromatosis.
Powell LW; Dixon JL; Hewett DG
Best Pract Res Clin Haematol; 2005 Jun; 18(2):221-34. PubMed ID: 15737886
[TBL] [Abstract][Full Text] [Related]
23. Noniatrogenic haemochromatosis in congenital dyserythropoietic anaemia type II is not related to C282Y and H63D mutations in the HFE gene: report on two brothers.
Van Steenbergen W; Matthijs G; Roskams T; Fevery J
Acta Clin Belg; 2002; 57(2):79-84. PubMed ID: 12152243
[TBL] [Abstract][Full Text] [Related]
24. Heterozygous recipient and donor HFE mutations associated with a hereditary haemochromatosis phenotype after liver transplantation.
Wigg AJ; Harley H; Casey G
Gut; 2003 Mar; 52(3):433-5. PubMed ID: 12584229
[TBL] [Abstract][Full Text] [Related]
25. HFE based re-evaluation of heterozygous hemochromatosis.
Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
[TBL] [Abstract][Full Text] [Related]
26. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload.
Townsend A; Drakesmith H
Lancet; 2002 Mar; 359(9308):786-90. PubMed ID: 11888608
[TBL] [Abstract][Full Text] [Related]
27. Testing families with HFE-related hereditary haemochromatosis.
Siezenga MA; Rasp E; Wijermans PW
Neth J Med; 2004 May; 62(5):156-9. PubMed ID: 15366698
[TBL] [Abstract][Full Text] [Related]
28. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
29. Mutations of the HFE gene among Turkish hereditary hemochromatosis patients.
Simsek H; Balaban YH; Yilmaz E; Sumer H; Buyukasik Y; Cengiz C; Ozcebe O; Hascelik G; Tatar G
Ann Hematol; 2005 Oct; 84(10):646-9. PubMed ID: 15871018
[TBL] [Abstract][Full Text] [Related]
30. Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis.
Kelleher T; Ryan E; Barrett S; Sweeney M; Byrnes V; O'Keane C; Crowe J
Gut; 2004 Aug; 53(8):1174-9. PubMed ID: 15247188
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in understanding haemochromatosis: a transition state.
Robson KJ; Merryweather-Clarke AT; Cadet E; Viprakasit V; Zaahl MG; Pointon JJ; Weatherall DJ; Rochette J
J Med Genet; 2004 Oct; 41(10):721-30. PubMed ID: 15466004
[TBL] [Abstract][Full Text] [Related]
32. Changing aspects of HFE-related hereditary haemochromatosis and endeavours to early diagnosis.
Jacobs EM; Verbeek AL; Kreeftenberg HG; van Deursen CT; Marx JJ; Stalenhoef AF; Swinkels DW; de Vries RA
Neth J Med; 2007 Dec; 65(11):419-24. PubMed ID: 18079564
[TBL] [Abstract][Full Text] [Related]
33. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women.
Roe MA; Spinks C; Heath AL; Harvey LJ; Foxall R; Wimperis J; Wolf C; Fairweather-Tait SJ
Br J Nutr; 2007 Mar; 97(3):544-9. PubMed ID: 17313717
[TBL] [Abstract][Full Text] [Related]
34. Dual diagnoses of hereditary hyperferritinaemia-cataract syndrome and hereditary haemochromatosis.
Hughes M; Vosylius P
Clin Lab Haematol; 2006 Oct; 28(5):357-9. PubMed ID: 16999731
[TBL] [Abstract][Full Text] [Related]
35. Frequency of HFE H63D, S65C, and C282Y mutations in patients with iron overload and controls from Toledo, Spain.
de Diego C; Murga MJ; MartÃnez-Castro P
Genet Test; 2004; 8(3):263-7. PubMed ID: 15727249
[TBL] [Abstract][Full Text] [Related]
36. Risk of iron overload in carriers of genetic mutations associated with hereditary haemochromatosis: UK Food Standards Agency workshop.
Singh M; Ashwell M; Sanderson P; Cade J; Moreton J; Fairweather-Tait S; Roe M; Marx JJ; Worwood M; Cook JD
Br J Nutr; 2006 Oct; 96(4):770-3. PubMed ID: 17010238
[TBL] [Abstract][Full Text] [Related]
37. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
[TBL] [Abstract][Full Text] [Related]
38. [Hereditary hemochromatosis].
Dantas W
Rev Gastroenterol Peru; 2001; 21(1):42-55. PubMed ID: 12170286
[TBL] [Abstract][Full Text] [Related]
39. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
[TBL] [Abstract][Full Text] [Related]
40. Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice.
Utzschneider KM; Kowdley KV
Nat Rev Endocrinol; 2010 Jan; 6(1):26-33. PubMed ID: 20010968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
